怡康医药YIKANG品牌怎么样 申请店铺

更新时间:2024-10-28
怡康医药YIKANG是哪个国家的品牌?「怡康医药YIKANG」是 西安怡康医药连锁有限责任公司 旗下著名品牌。该品牌发源于陕西省西安市,在2001年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
怡康医药YIKANG怎么样

陕西怡康医药有限责任公司成立于2001年,目前拥有全资及控股公司14家,全省连锁葯店700余家,经营范围涵盖化学药制剂、抗生素、生化药品、生物制品、中成药、中药饮片、中药材、医疗器械、保健品、消毒用品等,经营品规10000多种。药品配送覆盖全省85%以上的地区,约107个县,企业员工6000余人,年度总销售额可达60亿元。

陕西怡康医药有限责任公司以医药经营为核心,业务覆盖了医药零售批发、医药物流、医药电商三大业务板块。批发销售网络覆盖省内各地市级医院及部队医院;市、县、乡镇,配送区域至:延安宝塔区、延长县、延川县、渭南市富平县、安康市汉滨区、西安市周至县、雁塔区等范围,并于2014年9月份成功入围宝鸡市高新区、扶风县、凤县“三统一”中标药品配送。经由2016年整合统计,陕西怡康医药现配送网络已覆盖各区县级及基层医疗机构,配送医疗机构约7000家,覆盖率100%,药品配送率达95%以上,累计销售逐年递增;公司配送中心库房总面积11000平方米,库房总面积11000平米,库存品规10000多个,拥有配送车辆近50辆,冷链车20辆。广阔的网络体系和信息化、自动化的运营体系,科学、合理、严谨的管理模式,以KSOA企业信息融通平台、WMS仓储管理、协同商务、U890用友财务、GPS定位系统、HR人力资源软件等现代化管理体系为业务、仓储、上下游客户、财务,物流、人力六大系统服务,使管理更加流程化、科学化。

2016年集团公司特斥资近2亿元倾力打造了总建筑面积5万余平米的“怡康医药集团物流中心”,集办公、物流配送及生活服务为一体,并按照新版GSP要求配备完善的温湿度、自动监控等基础设施;优良的电子分拣系统,大大提高了复核分拣效率,堪称现代医药企业办公中心典范;2014年开始布局医药电商。2015年7月7日“怡康到家”APP正式上线,标志着怡康医药从传统医药零售,迈入了以怡康到家自有平台和天猫、京东、百度等第三方平台相结合的立体化销售模式。


Shaanxi Yikang Pharmaceutical Co., Ltd. was founded in 2001. At present, it has 14 wholly-owned and holding companies and more than 700 chain drugstores in the province. Its business scope covers chemical pharmaceutical preparations, antibiotics, biochemical drugs, biological products, Chinese patent medicine, Chinese herbal medicines, medical devices, health care products, disinfection products, etc., with more than 10000 product specifications. Drug distribution covers more than 85% of the province, about 107 counties, with more than 6000 employees, and the total annual sales volume can reach 6 billion yuan. Shaanxi Yikang Pharmaceutical Co., Ltd. takes pharmaceutical business as the core, covering three business sectors: pharmaceutical retail and wholesale, pharmaceutical logistics and pharmaceutical e-commerce. The wholesale sales network covers all municipal hospitals and military hospitals in the province; cities, counties and towns, and the distribution areas are: Baota District, Yanchang County, Yanchuan County, Fuping County, Weinan City, Hanbin District, Ankang City, Zhouzhi County and Yanta District of Xi'an City, etc. in September 2014, it was successfully shortlisted for the "three unified" bid winning drug distribution in Baoji high tech Zone, Fufeng County and Fengxian County. According to the integrated statistics in 2016, the distribution network of Shaanxi Yikang Pharmaceutical Co., Ltd. now covers county-level and grass-roots medical institutions in all regions, with 7000 distribution medical institutions, 100% coverage, and more than 95% drug distribution rate, with the cumulative sales increasing year by year; the total area of the company's distribution center warehouse is 11000 square meters, with 11000 square meters, more than 10000 inventory specifications, nearly 50 distribution vehicles, and cold 20 chain cars. Wide network system, information and automation operation system, scientific, reasonable and rigorous management mode, and six systems of business, storage, upstream and downstream customers, finance, logistics and human resources, which are modern management systems such as ksoa enterprise information fusion platform, WMS storage management, collaborative business, u890 UFIDA finance, GPS positioning system, HR human resources software, etc., serve to make management more efficient Add process and scientific. In 2016, the group company invested nearly 200 million yuan to build the "Yikang Pharmaceutical Group Logistics Center" with a total building area of more than 50000 square meters, integrating office, logistics distribution and life services, and equipped with complete temperature and humidity, automatic monitoring and other infrastructure according to the requirements of the new GSP. The excellent electronic sorting system has greatly improved the efficiency of recheck sorting, which can be called the modern pharmaceutical enterprise office Model of public center; medical e-commerce began to be distributed in 2014. On July 7, 2015, "Yikang home" app was officially launched, marking that Yikang medicine has entered into a three-dimensional sales mode combining Yikang home's own platform with tmall, JD, Baidu and other third-party platforms from traditional medicine retail.

本文链接: https://brand.waitui.com/0bd2ddbd5.html 联系电话:400-799-9120,029-89633308

千城特选小程序码

7×24h 快讯

中央汇金三季度继续出手,3000亿元增持五大宽基ETF

最新披露的基金2024年三季报证实,在三季度的震荡行情中,中央汇金资产管理有限责任公司(下称“中央汇金”)继续增持ETF,仅4只沪深300ETF和华夏上证50ETF,就耗资约3000亿元。从年内的资金流向来看,大量资金借道ETF入市,ETF净申购额接近8800亿元,仅华泰柏瑞沪深300ETF净申购额就高达2002亿元。(上证报)

31分钟前

氧化铝价格创近十年新高,供给收紧局面难改

自10月22日盘中一度突破5000元/吨关口后,国内期货市场上氧化铝主力合约2411价格近日已稳定在5100元/吨上方,刷新历史高点,较一年前这一新品种上市之初的价格近乎翻番。而现货市场上,当前氧化铝价格也已逼近5000元/吨,为近十余年来高位。作为电解铝重要的生产原材料,氧化铝价格持续走高,已显著冲击了铝企的盈利水平。相较今年5月份,铝企单吨盈利已缩减超千元,个别企业甚至陷入亏损区间。氧化铝价格高位运行,对下游形成冲击,产业链负反馈效应渐显。不过分析人士多认为,当前氧化铝供给端未释放预期,市场供需矛盾尚存,短期价格强势格局或难改。(证券时报)

31分钟前

逾800家公司披露股东回报规划,稳步提升A股估值

近期,A股公司分红积极性持续高涨,分红金额屡创新高。统计发现,今年合计已有813家公司披露了三年股东回报规划并锁定最低分红率,为近四年来最多。年化估算预计将有957家公司披露最低分红方案,有望刷新年度历史最高纪录。同时,大量龙头公司展现出引领风范。数据显示,今年以来已经有4家千亿市值公司披露了未来三年每年不低于30%分红率的股东回报规划,此前五年合计只有3家千亿市值公司披露了类似承诺。发布股东回报规划的上市公司数量大幅增长,表明A股分红透明度进一步加大,有助于稳步提升A股估值。(证券时报)

32分钟前

波音公司据悉计划最快在周一将进行超过150亿美元融资

波音公司计划最快在周一将进行超过150亿美元的融资。(财联社)

32分钟前

自营业务驱动,多数券商三季度业绩回暖

10月25日,东方财富、湘财股份、国元证券、国盛金控等上市券商及上市券商主体纷纷发布三季度“成绩单”。10月23日,首创证券披露首份券商三季报。总体来看,首批券商三季报业绩出现分化,有的前三季度营收净利润双双实现同比正增长,有的业绩小幅下滑。不过,多数券商第三季度业绩普遍回暖。分业务来看,自营业务仍是券商业绩增长主要驱动因素,如东方财富、首创证券等自营业务均实现同比增长。(上证报)

32分钟前

本页详细列出关于怡康医药YIKANG的品牌信息,含品牌所属公司介绍,怡康医药YIKANG所处行业的品牌地位及优势。
咨询